Neither losartan nor atenolol reduce collagen markers beyond blood pressure reduction in hypertension. A LIFE substudy
Author(s) -
Mikkel Christensen,
Michael Hecht Olsen,
Lars Juhl Jensen,
Hans Ibsen
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.03.477
Subject(s) - medicine , losartan , atenolol , procollagen peptidase , blood pressure , n terminal telopeptide , left ventricular hypertrophy , endocrinology , diastole , cardiology , angiotensin ii , alkaline phosphatase , biochemistry , chemistry , osteocalcin , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom